+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 518 Pages
  • Global
From
Cough and Cold Preparations Market Report 2025 - Product Thumbnail Image

Cough and Cold Preparations Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Asthma Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Asthma Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
HP (High Potency) APIs Market Report 2025 - Product Thumbnail Image

HP (High Potency) APIs Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Pharmaceutical Drugs Market Report 2025 - Product Thumbnail Image

Pharmaceutical Drugs Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033

  • Report
  • February 2025
  • 150 Pages
  • Global
From
Lower Respiratory Tract Therapeutics Market Report 2025 - Product Thumbnail Image

Lower Respiratory Tract Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nasal Polyps Treatment Market Report 2025 - Product Thumbnail Image

Nasal Polyps Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Biologics Market Report 2025 - Product Thumbnail Image

Biologics Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
Cystic Fibrosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Cystic Fibrosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • July 2022
  • 112 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 88 Pages
  • Global
From
COPD Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

COPD Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 109 Pages
  • Global
From
Global Mergers and Acquisitions (M&A) Deals in 2021 - Top Themes in the Pharmaceuticals Sector - Thematic Research - Product Thumbnail Image

Global Mergers and Acquisitions (M&A) Deals in 2021 - Top Themes in the Pharmaceuticals Sector - Thematic Research

  • Report
  • January 2022
  • 28 Pages
  • Global
From
Vectura Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Vectura Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2025
  • 50 Pages
From
Vectura Group Plc - Strategic SWOT Analysis Review - Product Thumbnail Image

Vectura Group Plc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • January 2025
  • 25 Pages
From
Vectura Group Limited - Company Profile and SWOT Analysis - Product Thumbnail Image

Vectura Group Limited - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2025
  • 41 Pages
From
Vectura Group Plc - Product Pipeline Analysis, 2022 Update - Product Thumbnail Image

Vectura Group Plc - Product Pipeline Analysis, 2022 Update

  • Company Profile
  • July 2022
  • 37 Pages
From
Loading Indicator